MEDICENNA THERAPEUTICS CORP (MDNA.CA) Stock Analyst Ratings
TSX:MDNA - CA58490H1073 - Common Stock
1.04 CAD
-0.02 (-1.89%)
ChartMill assigns a Buy % Consensus number of 83% to MDNA.CA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 3.67. This target is 252.89% above the current price.
MDNA.CA was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about MDNA.CA.
In the previous month the buy percentage consensus was at a similar level.
MDNA.CA was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-11-29 | Guggenheim Securities | Initiate | Buy |
| 2022-11-29 | STA Research | Downgrade | Speculative Buy |
| 2022-09-29 | STA Research | Maintains | Speculative Buy |
| 2022-09-29 | HC Wainwright | Downgrade | Buy |
| 2022-08-16 | Bloom Burton | Downgrade | Buy |
| 2022-08-16 | Jones Trading | Downgrade | |
| 2022-08-10 | Oppenheimer Holdings | Initiate | Buy |
| 2022-08-10 | STA Research | Reiterate | Speculative Buy |
| 2022-07-28 | Bloom Burton | Maintains | Buy |
| 2022-06-23 | STA Research | Maintains | Speculative Buy |
| 2022-06-23 | HC Wainwright | Reiterate | Buy |
| 2022-04-13 | Brookline Capital | Upgrade | Buy |
| 2022-03-15 | Maxium Group | Initiate | Buy |
| 2021-09-22 | Bloom Burton | Initiate | Buy |